Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.

Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.

BACKGROUND:To investigate the diagnostic and prognostic performances of 18F-FDG PET/CT measures of metabolic tumour burden in patients with neurofibromatosis type-1 (NF1), suspect of malignant transformation. METHODS:This retrospective study included 49 patients (15-60 years old, 30 women) with a di...

Full description

Bibliographic Details
Main Authors: Axel Van Der Gucht, Ouidad Zehou, Soraya Djelbani-Ahmed, Laurence Valeyrie-Allanore, Nicolas Ortonne, Pierre Brugières, Pierre Wolkenstein, Alain Luciani, Alain Rahmouni, Emilie Sbidian, Emmanuel Itti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4795780?pdf=render

Internet

http://europepmc.org/articles/PMC4795780?pdf=render

Similar Items